The Need

 

Healthcare workers incur 2 million needlestick injuries (NSIs) per year that result in infections with hepatitis B and C and HIV. Research has shown 40–75% underreporting of these injuries. In the USA alone there are 800,000 NSI reported annually by health care workers. (source:WHO)

With the increased awareness about accidental needle stick injuries and growing emphasis on occupational safety, the safety injection devices have emerged as one of the most popular and preferred delivery devices.

Several organizations including OSHA and FDA have displayed concern about the prevention of needlestick injuries and, as such, issued regulatory guidelines. With the advent of the Needlestick Safety and Prevention Act and enforcement of other regulatory laws, the use of medical safety devices including safety syringes and safety needles have gained immense importance.

15 billion syringes are used annually around the world. Safety syringes currently constitute approximately 10% of the total market, or about 1.5 billion units per annum. This number is increasing each year as more countries legislate to make safety syringes mandatory. Current legislation exists in the USA, Spain, Switzerland and Taiwan.

Global Safety Syringes Market was valued at USD 3.41 billion in 2012 and is expected to grow at a CAGR of 9.7% from 2013 to 2019, to reach an estimated value of USD 6.50 billion by 2019. (source:Roots Analysis Private Limited)

About Needlestick Injuries


Direct Costs
    Short Term
  • Blood Sampling
  • Urgent Testing
  • Vaccinations
  • Health Care Visits
  • Post-exposure prophylaxis

    Long Term
  • HCW Counseling
  • Follow-up blood test
  • Long term treatmernt
Indirect Costs
    Short Term
  • Time Loss due to anxiety & distress
  • Adminstrative effort
 
 

    Long Term
  • Loss of HCW work days
  • Higher insurance premiums
  • Associated litigations
  • Compensation claims
impact of neddlestick injuries
  • Emotional trauma
  • Distress
  • Impairment on family & social relationships
  • Social stigma
  • Unpleasant side effects of treatment drugs
  • Staff retention
  • Infection risk to patients
  • Illness
  • Death

Copyright 2015. Shiva Medicare Limited (India). All Rights Reserved.